Can alprazolam, cyclobenzaprine, pantoprazole, simvastatin, or vitamin B12 increase eosinophil count in blood work?

Medication-Induced Eosinophilia Assessment

Among the medications listed, pantoprazole is the most likely culprit for elevated eosinophils, though this is a rare adverse reaction. The other medications (alprazolam, cyclobenzaprine, simvastatin, vitamin B12, and Xanax) are not commonly associated with eosinophilia.

Evidence-Based Analysis

Pantoprazole (Proton Pump Inhibitor)

Pantoprazole can cause Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome, a severe T-cell-mediated reaction characterized by rash, fever, eosinophilia, and visceral involvement 1, 2.

• A recent case documented pantoprazole-induced DRESS with eosinophil percentage rising from 0.5% to 18.4% over several days, with resolution occurring within 10 days of drug cessation 1
• Cross-reactivity among PPIs is documented, with esomeprazole being the most commonly implicated PPI (52.4%), followed by pantoprazole (19.1%) 2
• The FDA label for pantoprazole does not specifically list eosinophilia as a common side effect, but post-marketing surveillance has identified this rare complication 3

Other Medications - Low Probability

Alprazolam/Xanax (same drug): The FDA label and pharmacokinetic data show no association with eosinophilia 4. These benzodiazepines are metabolized via CYP3A4 but do not typically cause blood count abnormalities.

Cyclobenzaprine: Not mentioned in any of the provided evidence as causing eosinophilia. Muscle relaxants are rarely associated with this finding.

Simvastatin: The FDA label details extensive pharmacokinetic data but does not list eosinophilia as an adverse effect 5. Statins are not typically associated with elevated eosinophils.

Vitamin B12: Paradoxically, the pantoprazole FDA label warns that long-term PPI use (>3 years) can cause LOW vitamin B12 levels, not elevated eosinophils 3. B12 supplementation itself does not cause eosinophilia.

Clinical Approach

Immediate Assessment

1. Check timing: Eosinophilia from DRESS typically occurs 2-8 weeks after drug initiation (median 3 weeks for PPIs) 1, 2

2. Look for associated symptoms:

   • Rash (macular erythema with desquamation)
   • Fever
   • Lymphadenopathy
   • Liver enzyme elevation
   • Renal dysfunction

3. Quantify the eosinophilia:

   • Mild: 0.5-1.5 × 10⁹/L
   • Moderate: 1.5-5.0 × 10⁹/L
   • Severe: >5.0 × 10⁹/L 6

Management Algorithm

If eosinophilia is isolated (no systemic symptoms):

• Consider non-drug causes first: allergic conditions (asthma, eczema, hay fever), parasitic infections 6, 7
• Review all medications, prioritizing pantoprazole as the suspect
• Monitor eosinophil count weekly

If DRESS syndrome is suspected (eosinophilia + rash + fever):

• Immediately discontinue pantoprazole 1
• Expect defervescence within 48 hours and eosinophil normalization within 10 days if drug-related 1
• Do NOT substitute with another PPI due to cross-reactivity risk 2
• Consider H2-receptor antagonists (ranitidine, famotidine) as alternatives if acid suppression is needed

Important Caveats

• Drug-induced eosinophilia is a diagnosis of exclusion—rule out parasitic infections (especially in travelers), allergic conditions, and hematologic malignancies first 6, 7
• If eosinophilia persists >3 months at ≥1.5 × 10⁹/L after drug cessation and infectious causes are excluded, refer to hematology for hypereosinophilic syndrome evaluation 6
• The patient is taking alprazolam 1 mg AND Xanax 0.5 mg—these are the same drug; this represents duplicate therapy and should be consolidated to prevent benzodiazepine toxicity